Bruk av videosamtale i behandling av tuberkulose-sykdom i Nord-Norge

Bendiksen, Renate; Ovesen, Therese; Asfeldt, Anne Mette; Halvorsen, Dag S.; Gravningen, Kirsten

doi:10.4045/tidsskr.19.0322

Cited by 5 publications

(13 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Garfein [19] too found vDOT to be 32% less costly than DOT. Chuck [3] , Holzschuh [4] , Story [5] , and Bendiksen [6] concurred, stating that video technology also required less staff time compared to in-person DOT. Patients were understood to receive the same treatment with greater efficiency.…”

Section: Resultsmentioning

confidence: 99%

Patient perceptions of video directly observed therapy for tuberculosis: a systematic review

Chen,

Owaisi,

Goldschmidt

et al. 2024

Journal of Clinical Tuberculosis and Other Mycobacterial Diseas

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Patient perceptions of video directly observed therapy for tuberculosis: a systematic review

Chen,

Owaisi,

Goldschmidt

et al. 2024

Journal of Clinical Tuberculosis and Other Mycobacterial Diseas

View full text Add to dashboard Cite

“…This was often interpreted as relating to VOT, especially asynchronous VOT, being provided 7-days per week and being less affected by staffing shortages, strikes, and national holidays. Several studies reported no difference in adherence rates between VOT and DOT 5,17,22,35,40,47,57,64 . Perry et al 52 reported more missing doses (average 3.4% vs. 1.3%, respectively; P < 0.001) over a median period of 27 weeks but similar adherence rates (96% vs. 90%; P=0.326) in VOT vs DOT.…”

Section: Resultsmentioning

confidence: 99%

“…All studies reported that VOT was feasible regardless of urbanicity (although most were conducted in urban/peri-urban settings), country income level or population context. However, the most frequently reported challenges to feasibility were lack of or unreliable internet coverage 5,25,26,28,36,39,42,48,50,56,57,61,75 , low quality of videos or incomplete dose verification 17,26,28,34,35,[40][41][42]60,70 and other technical issues including battery problems 18,22,25,28,31,33,49,50,58 .…”

Section: Feasibilitymentioning

confidence: 99%

“…Except for a single study in the Philippines 26 , in which uptake of VOT was low (36%), all found VOT acceptable to people with TB and healthcare providers. A preference amongst people with TB for VOT over DOT was reported to relate to increased convenience, time-saving, and flexibility [22][23][24][25][32][33][34]36,37,[40][41][42]48,54 . Amongst healthcare workers, two studies from China and The Philippines, reported a preference for VOT over DOT 26,37 .…”

Section: Acceptabilitymentioning

confidence: 99%

See 1 more Smart Citation

Video Observed Therapy (VOT) for People with Tuberculosis (TB): A Scoping Review

Du Thinh,

Morgan,

Pereira

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: Tuberculosis (TB) remains a significant cause of morbidity and mortality globally, disproportionately affecting low- and middle-income countries (LMIC). Accessing Directly Observed Therapy (DOT) is associated with out-of-pocket costs and stigma. Video-observed therapy (VOT) is an alternative to DOT but evidence from LMIC with high TB burden is limited. To make recommendations for future VOT-related research and inform the design of a pilot implementation of VOT for people with multi-drug resistant TB (MDR-TB) in Mozambique, we did a scoping review of the evidence on VOT for people with TB. Methodology: We systematically searched five scientific databases and key grey literature repositories to identify eligible abstracts. Abstracts were reviewed and full-text records were identified and evaluated. Data from full-text records were extracted into four implementation theme categories: Feasibility, Acceptability, Cost, and Effectiveness (FACE). Content analysis was used to describe implementation successes and challenges, comparing VOT versus DOT where possible. The Crowe Critical Appraisal Tool (CCAT) was used to evaluate the quality of studies. Results: In total, 66 records were identified: 47 primary research studies, 13 reviews, and six grey literature documents. All studies were graded as moderate to high quality and reported against at least one FACE category. Studies from urban settings (n=34) and HIC (n=33) predominated. Where measured and described, VOT implementation was reported to be feasible (43/43, 100%) and acceptable (43/44, 97%). Of the 18/20 (90%) studies describing cost data, VOT was reported to offer savings to the health system compared to DOT. Patient costs were under-reported. Of the 21/23 (91%) studies describing effectiveness to improve adherence to TB treatment, VOT was reported to be non-inferior to DOT. Conclusion: In HIC settings, VOT was reported as feasible, acceptable, and similarly effective alternative to DOT. Further evidence on VOT is needed from LMIC with high TB burden.

show abstract

“…Medication event monitoring system devices use openings of electronic containers and lids but have well-documented inaccuracies based on mismatches between openings and actual pill taking [19][20][21][22][23][24]. Smartphone apps incorporating SMS text messaging are based on self-report [25] or send videos [26] for later viewing and assessment. In contrast to these surrogate technologies, ISs signal when medication reaches the gastric track and are able to capture individual daily behavior patterns in real time, providing insight into variations in daily medication adherence.…”

Section: Introductionmentioning

confidence: 99%

User Experience of Persons Using Ingestible Sensor–Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study

Browne,

Umlauf,

Moore

et al. 2024

JMIR Mhealth Uhealth

View full text Add to dashboard Cite

Background A digital health technology’s success or failure depends on how it is received by users. Objectives We conducted a user experience (UX) evaluation among persons who used the Food and Drug Administration–approved Digital Health Feedback System incorporating ingestible sensors (ISs) to capture medication adherence, after they were prescribed oral pre-exposure prophylaxis (PrEP) to prevent HIV infection. We performed an association analysis with baseline participant characteristics, to see if “personas” associated with positive or negative UX emerged. Methods UX data were collected upon exit from a prospective intervention study of adults who were HIV negative, prescribed oral PrEP, and used the Digital Health Feedback System with IS-enabled tenofovir disoproxil fumarate plus emtricitabine (IS-Truvada). Baseline demographics; urine toxicology; and self-report questionnaires evaluating sleep (Pittsburgh Sleep Quality Index), self-efficacy, habitual self-control, HIV risk perception (Perceived Risk of HIV Scale 8-item), and depressive symptoms (Patient Health Questionnaire–8) were collected. Participants with ≥28 days in the study completed a Likert-scale UX questionnaire of 27 questions grouped into 4 domain categories: overall experience, ease of use, intention of future use, and perceived utility. Means and IQRs were computed for participant total and domain subscores, and linear regressions modeled baseline participant characteristics associated with UX responses. Demographic characteristics of responders versus nonresponders were compared using the Fisher exact and Wilcoxon rank-sum tests. Results Overall, 71 participants were enrolled (age: mean 37.6, range 18-69 years; n=64, 90% male; n=55, 77% White; n=24, 34% Hispanic; n=68, 96% housed; and n=53, 75% employed). No demographic differences were observed in the 63 participants who used the intervention for ≥28 days. Participants who completed the questionnaire were more likely to be housed (52/53, 98% vs 8/10, 80%; P=.06) and less likely to have a positive urine toxicology (18/51, 35% vs 7/10, 70%; P=.08), particularly methamphetamine (4/51, 8% vs 4/10, 40%; P=.02), than noncompleters. Based on IQR values, ≥75% of participants had a favorable UX based on the total score (median 3.78, IQR 3.17-4.20), overall experience (median 4.00, IQR 3.50-4.50), ease of use (median 3.72, IQR 3.33-4.22), and perceived utility (median 3.72, IQR 3.22-4.25), and ≥50% had favorable intention of future use (median 3.80, IQR 2.80-4.40). Following multipredictor modeling, self-efficacy was significantly associated with the total score (0.822, 95% CI 0.405-1.240; P<.001) and all subscores (all P<.05). Persons with more depressive symptoms reported better perceived utility (P=.01). Poor sleep was associated with a worse overall experience (−0.07, 95% CI −0.133 to −0.006; P=.03). Conclusions The UX among persons using IS-enabled PrEP (IS-Truvada) to prevent HIV infection was positive. Association analysis of baseline participant characteristics linked higher self-efficacy with positive UX, more depressive symptoms with higher perceived utility, and poor sleep with negative UX.

show abstract

Bruk av videosamtale i behandling av tuberkulose-sykdom i Nord-Norge

Cited by 5 publications

References 7 publications

Patient perceptions of video directly observed therapy for tuberculosis: a systematic review

Patient perceptions of video directly observed therapy for tuberculosis: a systematic review

Video Observed Therapy (VOT) for People with Tuberculosis (TB): A Scoping Review

User Experience of Persons Using Ingestible Sensor–Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study

Contact Info

Product

Resources

About